Neurol. praxi. 2026;27(4):303-307 | DOI: 10.36290/neu.2026.030

Pain management in patients with rheumatic disease

MUDr. Jana Hrubešová
Ambulance pro léčbu bolesti KARIM FN Hradec Králové

Pain is one of the most distressing symptoms of revmatology deseasess and, if not properly managed, can significantly reduce a patient's quality of life and limit their functional abilities. Effective pain management should be an essential part of a comprehensive treatment plan for patients with this condition. When standard analgesic treatments are insufficient, minimally invasive techniques may be considered, offering rapid and effective pain relief when appropriately indicated.

Keywords: rheumatic disease, pain management, non-opioid analgesics, opioids, cannabis.

Received: May 11, 2026; Revised: June 7, 2026; Accepted: June 8, 2026; Prepublished online: June 8, 2026; Published: October 2, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubešová J. Pain management in patients with rheumatic disease. Neurol. praxi. 2026;27(4):303-307. doi: 10.36290/neu.2026.030.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 2.10.2027

    References

    1. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, Eur J Neurol. 2010;17(9). Go to original source... Go to PubMed...
    2. Dingle JT. The effect of NSAIDs on human articular cartilage glycosaminoglycan synthesis. Eur J Rheum Inflam. 1996;16:47-52.
    3. Hakl M. Léčba chronické bolesti, atypické opioidy. Neurol.praxi. 2024;25(6):478-481. Go to original source...
    4. Hakl M, Fricová J, Doporučené postupy pro farmakoterapii bolesti - speciální část, Bolest. 2017, Suppl 3.
    5. Kolektiv autorů: Metodické pokyny pro farmakoterapii bolesti. Bolest. 2022:Suppl.
    6. Kozák J, Lejčko J, Vrba I, et al. Opioidy, Mladá fronta a. s. 2021.
    7. Landa L, Juřica J, et al. Léčebné konopí v současné medicínské praxi. Praha: Grada Publishing, a. s., 2020.
    8. Olejárová M. Lokální nesteroidní antirevmatika v revmatologii. Praktické lékárenství. 2008;4(2).
    9. Pavelka K. Bolest u osteoartrózy. Praha: Tigis 2023.
    10. Rokyta R, Kršiak M, Kozák J (eds.). Bolest (2. vydání), Tigis, Praha 2012.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.